Xaciato (Clindamycin Phosphate) Patent Expiration, LOE Window & CMS Spending

Xaciato (Clindamycin Phosphate) by Organon: FDA Orange Book LOE 2036-09-22, 23 AB generics, $189K 2024 CMS Part D & Medicaid spend.

Regulatory & Reimbursement Dimension Verified Value
Consolidated SponsorOrganon
FDA Application & PathwayN215650 (NDA)
Exclusivity / Cliff HorizonLong-Dated Protection (2036+)
Core Active-Ingredient LOE DateNot listed / N/A
Last Listed Patent or Exclusivity Date2036-09-22
Orange Book Patents (*PED Extensions)2 patents (0 *PED)
Active AB-Rated Generic Competitors23
2024 CMS Total Public Spend$189K
2024 Medicare Part D Spend$14K
2024 Medicaid Spend$175K
Reported Wholesale Price Change (CA SB 17)0 statutory filings in 2023 to 2026 panel

Related Filings Across Meru Platforms

Verified cross-ledger federal filings for Organon across sibling Meru public-data platforms.